Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study Academic Article Article uri icon

Overview

MeSH Major

  • Aging
  • DNA
  • Lymphocytes

abstract

  • Pharmacyclics LLC, an AbbVie Company.

publication date

  • October 2016

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(16)30212-1

PubMed ID

  • 27637985

Additional Document Info

start page

  • 1409

end page

  • 1418

volume

  • 17

number

  • 10